Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
AOD9604 does not meaningfully increase GH or IGF1 levels and is considered a modest, mechanistic fatsupport peptide rather than a cornerstone obesity treatment
NAMPT is essential for the G-CSF-induced myeloid differentiation via a [PMID: 19182797] Laboratory literature summary: NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway
Bodian M
NAD+ / SIRT1: Associated with elevated NAD+ and SIRT1 activation in preclinical studies [2] [3]
Clinical Weight Loss Results In a 12-week randomized clinical trial involving 300 obese adults, subjects receiving 1 mg daily of AOD-9604 lost an average of 2.6 kg compared to 0.8 kg in the placebo group
Many clients report improved energy, focus, and overall mood after just a few treatments
US$ 20.93
US$ 27.79
US$ 21.83
US$ 20.66
US$ 24.46
US$ 23.66
US$ 25.04
